Table 1.
Patients’ baseline characteristics
| Patients, n | 234 |
| Age (years), mean ± SD | 59.8 ± 10.7 |
| Male sex, n (%) | 186 (79) |
| BMI (kg/m2), mean ± SD | 27.7 ± 3.9 |
| Exam interval (months), median (IQR) | 32.4 (19.2 - 49.7) |
| Baseline SSS, median (IQR) | 6 (2 - 11) |
| Clinical risk factors | |
| Hypertension, n (%) | 117 (50) |
| Diabetes, n (%) | 30 (13) |
| Dyslipidemia, n (%) | 125 (53) |
| Family history CAD, n (%) | 99 (42) |
| Glucose intolerance, n (%) | 10 (4) |
| Current smoker, n (%) | 25 (11) |
| Past smoker, n (%) | 55 (24) |
| Positive stress test, n (%) | 26 (11) |
| Previous MI, n (%) | 18 (8) |
| Previous PCI, n (%) | 50 (21) |
| Medication use | |
| Beta-blockers, n (%) | 35 (15) |
| ACEI/ARB, n (%) | 45 (19) |
| Antiplatelet, n (%) | 46 (20) |
| Statin, n (%) | 59 (25) |
SD: standard deviation; BMI: body mass index; SSS: segment stenosis score; IQR: interquartile range; CAD: coronary artery disease; MI: myocardial infarction; PCI: percutaneous coronary intervention; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker.